Which has the lower trailing P/E, CI or NVS?

CI has the lower trailing P/E: CI trades at 11.20 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CI or NVS?

Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus NVS at 1.53%.

Does CI or NVS pay a bigger dividend?

CI yields 2.31% and NVS yields 3.38% based on trailing dividends and the latest price.

Is CI or NVS more profitable?

NVS runs the higher net margin — CI at 2.27% versus NVS at 22.93%.

How have CI and NVS total returns compared?

Over the past 10 years, CI delivered 8.63% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Cigna Corporation (CI) vs Novartis AG (NVS)

A side-by-side comparison of Cigna Corporation and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Cigna Corporation

$71.48B

$270.53HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

NVS

Novartis AG

$268.00B

$141.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — CI vs NVS

growth of $100 · dividends reinvested · last 10y

CI +138.5% (+9.1%/yr)NVS +219.0% (+12.3%/yr)NVS compounded faster over this window

CI NVS

CI vs NVS: by the numbers

•NVS is the larger company ($268.00B vs $71.48B market cap).
•CI trades at the lower trailing earnings multiple (11.20 vs 21.27 P/E), one valuation lens rather than an overall verdict.
•NVS converts more revenue to profit (22.93% vs 2.27% net margin).
•CI grew revenue faster over the past five years (11.11% vs 1.53% CAGR).
•NVS pays the higher dividend yield (3.38% vs 2.31%).

Metrics side by side

Valuation

Metric	CI	NVS
P/E ratio	11.20	21.27
Forward P/E	8.87	16.02
PEG ratio	N/A	1.38
P/S ratio	0.25	4.82
P/B ratio	1.68	6.45
EV / EBITDA	7.86	13.85
FCF yield	12.75%	5.90%

Profitability

Metric	CI	NVS
Gross margin	11.66%	74.44%
Operating margin	3.46%	30.54%
Net margin	2.27%	22.93%
ROE	15.05%	30.71%
ROIC	7.69%	13.93%

Dividends

Metric	CI	NVS
Dividend yield	2.31%	3.38%
Payout ratio	25.62%	71.50%

Growth (annualized)

Metric	CI	NVS
Revenue CAGR (5Y)	11.11%	1.53%
EPS CAGR (5Y)	-0.76%	15.42%
FCF CAGR (5Y)	-1.95%	8.92%
Total return CAGR (5Y)	7.73%	16.96%

Frequently asked

Which has the lower trailing P/E, CI or NVS?: CI has the lower trailing P/E: CI trades at 11.20 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CI or NVS?: Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus NVS at 1.53%.
Does CI or NVS pay a bigger dividend?: CI yields 2.31% and NVS yields 3.38% based on trailing dividends and the latest price.
Is CI or NVS more profitable?: NVS runs the higher net margin — CI at 2.27% versus NVS at 22.93%.
How have CI and NVS total returns compared?: Over the past 10 years, CI delivered 8.63% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full NVS analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio Novartis AG P/E ratio Cigna dividend yield Novartis AG dividend yield Cigna ROE Novartis AG ROE Cigna operating margin Novartis AG operating margin Cigna revenue growth Novartis AG revenue growth Cigna free cash flow Novartis AG free cash flow

Cigna & Novartis AG appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.